Parallax Volatility Advisers, L.P. Galapagos Nv Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$37.4 - $44.52 $620,840 - $739,032	16,600 New	16,600 $674,000
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $7.76 Million - $9.43 Million	165,100 New	165,100 $9.1 Million
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $1.32 Million - $1.66 Million	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $1.36 Million - $1.8 Million	15,000 New	15,000 $1.69 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.